Exact Mass: 352.1998
Exact Mass Matches: 352.1998
Found 56 metabolites which its exact mass value is equals to given mass value 352.1998,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Clidinium
(1s,4s)-3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-1-methyl-1-azabicyclo[2.2.2]octan-1-ium
Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. It inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites. It is used for the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-butyl-4-piperidinyl)-1-propanone
1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-butyl-4-piperidinyl)-1-propanone
Methyl (9Z)-8'-oxo-6,8'-diapo-6-carotenoate
Methyl (4Z,6E,8E,10E,12E,14E,16E)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoic acid
Methyl (9Z)-8-oxo-6,8-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).
2-(4-Hydroxy-3,5-di-tert-butylphenylthio)-hexanoic acid
2-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]hexanoic acid
Phenothiazine, 10-((N-butyl-2-piperidyl)methyl)-
10-[(1-butylpiperidin-2-yl)methyl]-10H-phenothiazine
11,17-Dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one
14,17-dihydroxy-2,8,15-trimethyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6,8-trien-5-one
methyl 6-deoxy-1,3-di-O-methyl-beta-D-ribo-hexosyl-(1->4)-2,6-dideoxy-3-O-methyl-alpha-D-arabino-hexopyranoside
methyl 6-deoxy-1,3-di-O-methyl-beta-D-ribo-hexosyl-(1->4)-2,6-dideoxy-3-O-methyl-alpha-D-arabino-hexopyranoside
(8E,16S)-16-Hydroxy-8-tricosene-4,6,17,19-tetraynoic acid
(8E,16S)-16-Hydroxy-8-tricosene-4,6,17,19-tetraynoic acid
all-E-citreomontanin|Citreomontanin|citreomontanine
all-E-citreomontanin|Citreomontanin|citreomontanine
Apo-8'-bixinal
methyl (2E,4Z,6E,8E,10E,12E,14E,16E)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoate
1-BENZYL-3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)UREA
1-BENZYL-3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)UREA
3-(3,4,5-TRIMETHOXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
3-(3,4,5-TRIMETHOXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
(2R,4R)-BOC-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID BENZYLAMINE SALT
(2R,4R)-BOC-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID BENZYLAMINE SALT
N-Isopropyl-3,5-dimethoxy-4-(2-morpholinoethoxy)benzamide
N-Isopropyl-3,5-dimethoxy-4-(2-morpholinoethoxy)benzamide
butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enamide,prop-2-enenitrile
butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enamide,prop-2-enenitrile
methyl (3S)-3-(3-carbamimidoylphenyl)-5-(4-carbamimidoylphenyl)pentanoate
methyl (3S)-3-(3-carbamimidoylphenyl)-5-(4-carbamimidoylphenyl)pentanoate
11,17-dihydroxy-6,10,13-trimethyl-17-prop-1-ynyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one
11,17-dihydroxy-6,10,13-trimethyl-17-prop-1-ynyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one
4-(3,5-dimethyl-1-piperidinyl)-N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-oxobutanamide
4-(3,5-dimethyl-1-piperidinyl)-N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-oxobutanamide
10-(3-Carboxypropyl)-3,6-bis(dimethylamino)acridinium
10-(3-Carboxypropyl)-3,6-bis(dimethylamino)acridinium
N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
(9R,17S)-9-fluoro-6,11,17-trihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(9R,17S)-9-fluoro-6,11,17-trihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
clidinium
clidinium
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
4-methoxy-5-methyl-6-(7,9,11-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl)pyran-2-one
4-methoxy-5-methyl-6-(7,9,11-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl)pyran-2-one
methyl (6e,8e,10e,12e,14e,16e)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoate
methyl (6e,8e,10e,12e,14e,16e)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoate
4-methoxy-5-methyl-6-[(1e,3e)-4-[(1r,6s,7s,8s)-1,3,5,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]buta-1,3-dien-1-yl]pyran-2-one
4-methoxy-5-methyl-6-[(1e,3e)-4-[(1r,6s,7s,8s)-1,3,5,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]buta-1,3-dien-1-yl]pyran-2-one
4-methoxy-5-methyl-6-[(1e,3e,5e,7e,9e,11e)-7,9,11-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl]pyran-2-one
4-methoxy-5-methyl-6-[(1e,3e,5e,7e,9e,11e)-7,9,11-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl]pyran-2-one
4-methoxy-5-methyl-6-(4-{1,3,5,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl}buta-1,3-dien-1-yl)pyran-2-one
4-methoxy-5-methyl-6-(4-{1,3,5,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl}buta-1,3-dien-1-yl)pyran-2-one
methyl (4z,6e)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoate
methyl (4z,6e)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoate
